Stem cell therapy treats psoriasis by rebalancing the immune system and repairing damaged skin. Mesenchymal stem cells (MSCs) regulate overactive T-cells that drive inflammation. This process restores a healthy immune balance, reduces silvery scales, and can provide a remission window of 3 to 12 months.
- Immune modulation: MSCs regulate Th17 and Th1 cells to stop systemic inflammation.
- Cytokine reduction: Secreted anti-inflammatory molecules like IL-10 calm skin flare-ups.
- Tissue repair: Growth factors encourage healthy skin regeneration and slow rapid cell turnover.
- Arthritis relief: Intravenous delivery reduces joint pain and inflammation in psoriatic arthritis cases.
Bookimed Expert Insight: Data suggests that while many seek treatment for chronic plaques, patients with erythrodermic psoriasis often see more dramatic initial results. Clinics like Memorial Göztepe Hospital utilize advanced diagnostics to track PASI scores. Experience counts here; choosing a dermatologist like Dr. Cuneyt Kara, who specializes specifically in chronic inflammatory skin diseases, ensures better protocol tailoring.
Patient Consensus: Patients often report noticeable skin improvement within 6 weeks, though some experience mild flu-like symptoms immediately after the infusion. While not a permanent cure, the significant reduction in plaque coverage offers a much-needed physical and emotional break from chronic symptoms.